Servicio de Información Comunitario sobre Investigación y Desarrollo - CORDIS

FP5

TARGETED GENE VECTOR Informe resumido

Project ID: QLK3-CT-1999-00364
Financiado con arreglo a: FP5-LIFE QUALITY
País: France

Validation of a Tetracycline conditional expression retroviral vector expressing efficiently and safely a therapeutic gene in glioblastoma in murine models

A tetracycline conditional expression retroviral vector, which has been validated in vitro, is currently being validated for its efficient and safe transduction of a therapeutic gene in models of murine and rat glioblastoma. The vector system is being tested for appropriate propagation and transgene expression within the tumour as well as for any detectable dissemination outside of the tumour. It is also being tested for its therapeutic efficacy, alone or in combination with retroviral vectors transducing other genes of interest.

Contacto

David KLATZMANN, (Professor)
Tel.: +33-142177461
Fax: +33-142177462
Correo electrónico
Síganos en: RSS Facebook Twitter YouTube Gestionado por la Oficina de Publicaciones de la UE Arriba